nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—Nelarabine—Abacavir—acquired immunodeficiency syndrome	0.162	0.351	CrCrCtD
Clofarabine—DCK—Lamivudine—acquired immunodeficiency syndrome	0.15	0.42	CbGbCtD
Clofarabine—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.146	0.316	CrCrCtD
Clofarabine—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.0805	0.175	CrCrCtD
Clofarabine—Decitabine—Lamivudine—acquired immunodeficiency syndrome	0.0728	0.158	CrCrCtD
Clofarabine—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0475	0.133	CbGbCtD
Clofarabine—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.043	0.121	CbGbCtD
Clofarabine—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.043	0.121	CbGbCtD
Clofarabine—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0412	0.116	CbGbCtD
Clofarabine—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0319	0.0895	CbGbCtD
Clofarabine—Cladribine—POLE3—acquired immunodeficiency syndrome	0.00266	1	CrCbGaD
Clofarabine—POLA1—retina—acquired immunodeficiency syndrome	0.0017	0.0429	CbGeAlD
Clofarabine—RRM2—skin of body—acquired immunodeficiency syndrome	0.00142	0.036	CbGeAlD
Clofarabine—RRM1—retina—acquired immunodeficiency syndrome	0.00135	0.034	CbGeAlD
Clofarabine—RRM1—skin of body—acquired immunodeficiency syndrome	0.00118	0.0299	CbGeAlD
Clofarabine—RRM2—lymphoid tissue—acquired immunodeficiency syndrome	0.00115	0.0291	CbGeAlD
Clofarabine—RRM2—digestive system—acquired immunodeficiency syndrome	0.00114	0.0288	CbGeAlD
Clofarabine—POLA1—blood—acquired immunodeficiency syndrome	0.00114	0.0287	CbGeAlD
Clofarabine—POLA1—bone marrow—acquired immunodeficiency syndrome	0.0011	0.0277	CbGeAlD
Clofarabine—RRM2—blood—acquired immunodeficiency syndrome	0.00108	0.0274	CbGeAlD
Clofarabine—POLA1—vagina—acquired immunodeficiency syndrome	0.00105	0.0266	CbGeAlD
Clofarabine—RRM2—bone marrow—acquired immunodeficiency syndrome	0.00105	0.0265	CbGeAlD
Clofarabine—DCK—retina—acquired immunodeficiency syndrome	0.00105	0.0264	CbGeAlD
Clofarabine—RRM2—vagina—acquired immunodeficiency syndrome	0.00101	0.0254	CbGeAlD
Clofarabine—POLA1—lung—acquired immunodeficiency syndrome	0.000995	0.0251	CbGeAlD
Clofarabine—RRM1—lymphoid tissue—acquired immunodeficiency syndrome	0.000958	0.0242	CbGeAlD
Clofarabine—RRM2—lung—acquired immunodeficiency syndrome	0.000951	0.024	CbGeAlD
Clofarabine—RRM1—digestive system—acquired immunodeficiency syndrome	0.000946	0.0239	CbGeAlD
Clofarabine—RRM1—blood—acquired immunodeficiency syndrome	0.000901	0.0228	CbGeAlD
Clofarabine—RRM2—nervous system—acquired immunodeficiency syndrome	0.000881	0.0222	CbGeAlD
Clofarabine—RRM1—bone marrow—acquired immunodeficiency syndrome	0.000872	0.022	CbGeAlD
Clofarabine—RRM1—spinal cord—acquired immunodeficiency syndrome	0.000868	0.0219	CbGeAlD
Clofarabine—RRM2—central nervous system—acquired immunodeficiency syndrome	0.000848	0.0214	CbGeAlD
Clofarabine—RRM1—vagina—acquired immunodeficiency syndrome	0.000835	0.0211	CbGeAlD
Clofarabine—RRM1—lung—acquired immunodeficiency syndrome	0.00079	0.02	CbGeAlD
Clofarabine—DCK—lymphoid tissue—acquired immunodeficiency syndrome	0.000744	0.0188	CbGeAlD
Clofarabine—DCK—digestive system—acquired immunodeficiency syndrome	0.000735	0.0186	CbGeAlD
Clofarabine—RRM1—nervous system—acquired immunodeficiency syndrome	0.000732	0.0185	CbGeAlD
Clofarabine—POLA1—brain—acquired immunodeficiency syndrome	0.000705	0.0178	CbGeAlD
Clofarabine—RRM1—central nervous system—acquired immunodeficiency syndrome	0.000704	0.0178	CbGeAlD
Clofarabine—DCK—blood—acquired immunodeficiency syndrome	0.0007	0.0177	CbGeAlD
Clofarabine—POLA1—lymph node—acquired immunodeficiency syndrome	0.000681	0.0172	CbGeAlD
Clofarabine—DCK—bone marrow—acquired immunodeficiency syndrome	0.000677	0.0171	CbGeAlD
Clofarabine—DCK—spinal cord—acquired immunodeficiency syndrome	0.000674	0.017	CbGeAlD
Clofarabine—RRM2—brain—acquired immunodeficiency syndrome	0.000673	0.017	CbGeAlD
Clofarabine—RRM2—lymph node—acquired immunodeficiency syndrome	0.00065	0.0164	CbGeAlD
Clofarabine—DCK—vagina—acquired immunodeficiency syndrome	0.000649	0.0164	CbGeAlD
Clofarabine—DCK—lung—acquired immunodeficiency syndrome	0.000614	0.0155	CbGeAlD
Clofarabine—DCK—nervous system—acquired immunodeficiency syndrome	0.000568	0.0144	CbGeAlD
Clofarabine—RRM1—brain—acquired immunodeficiency syndrome	0.000559	0.0141	CbGeAlD
Clofarabine—DCK—central nervous system—acquired immunodeficiency syndrome	0.000547	0.0138	CbGeAlD
Clofarabine—RRM1—lymph node—acquired immunodeficiency syndrome	0.00054	0.0136	CbGeAlD
Clofarabine—DCK—brain—acquired immunodeficiency syndrome	0.000434	0.011	CbGeAlD
Clofarabine—DCK—lymph node—acquired immunodeficiency syndrome	0.00042	0.0106	CbGeAlD
Clofarabine—ABCG2—blood—acquired immunodeficiency syndrome	0.000391	0.00986	CbGeAlD
Clofarabine—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000378	0.00954	CbGeAlD
Clofarabine—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000376	0.0095	CbGeAlD
Clofarabine—ABCG2—vagina—acquired immunodeficiency syndrome	0.000362	0.00914	CbGeAlD
Clofarabine—ABCG2—lung—acquired immunodeficiency syndrome	0.000342	0.00865	CbGeAlD
Clofarabine—ABCG2—brain—acquired immunodeficiency syndrome	0.000242	0.00612	CbGeAlD
Clofarabine—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000234	0.00591	CbGeAlD
Clofarabine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000715	CcSEcCtD
Clofarabine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.0001	0.000713	CcSEcCtD
Clofarabine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.0001	0.000713	CcSEcCtD
Clofarabine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.0001	0.000712	CcSEcCtD
Clofarabine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000711	CcSEcCtD
Clofarabine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	9.98e-05	0.000709	CcSEcCtD
Clofarabine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	9.97e-05	0.000708	CcSEcCtD
Clofarabine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	9.95e-05	0.000707	CcSEcCtD
Clofarabine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	9.95e-05	0.000706	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	9.95e-05	0.000706	CcSEcCtD
Clofarabine—Back pain—Lamivudine—acquired immunodeficiency syndrome	9.93e-05	0.000705	CcSEcCtD
Clofarabine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	9.9e-05	0.000703	CcSEcCtD
Clofarabine—Vomiting—Didanosine—acquired immunodeficiency syndrome	9.89e-05	0.000702	CcSEcCtD
Clofarabine—Agitation—Saquinavir—acquired immunodeficiency syndrome	9.89e-05	0.000702	CcSEcCtD
Clofarabine—Oedema—Delavirdine—acquired immunodeficiency syndrome	9.87e-05	0.000701	CcSEcCtD
Clofarabine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	9.83e-05	0.000698	CcSEcCtD
Clofarabine—Rash—Didanosine—acquired immunodeficiency syndrome	9.81e-05	0.000697	CcSEcCtD
Clofarabine—Infection—Delavirdine—acquired immunodeficiency syndrome	9.81e-05	0.000696	CcSEcCtD
Clofarabine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	9.8e-05	0.000696	CcSEcCtD
Clofarabine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	9.8e-05	0.000696	CcSEcCtD
Clofarabine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	9.8e-05	0.000696	CcSEcCtD
Clofarabine—Cough—Ritonavir—acquired immunodeficiency syndrome	9.76e-05	0.000693	CcSEcCtD
Clofarabine—Headache—Didanosine—acquired immunodeficiency syndrome	9.75e-05	0.000692	CcSEcCtD
Clofarabine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	9.73e-05	0.000691	CcSEcCtD
Clofarabine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	9.72e-05	0.00069	CcSEcCtD
Clofarabine—Somnolence—Indinavir—acquired immunodeficiency syndrome	9.71e-05	0.000689	CcSEcCtD
Clofarabine—Asthenia—Stavudine—acquired immunodeficiency syndrome	9.69e-05	0.000688	CcSEcCtD
Clofarabine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	9.68e-05	0.000687	CcSEcCtD
Clofarabine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	9.66e-05	0.000686	CcSEcCtD
Clofarabine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	9.66e-05	0.000686	CcSEcCtD
Clofarabine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	9.64e-05	0.000684	CcSEcCtD
Clofarabine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	9.63e-05	0.000684	CcSEcCtD
Clofarabine—Tremor—Lamivudine—acquired immunodeficiency syndrome	9.62e-05	0.000683	CcSEcCtD
Clofarabine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	9.6e-05	0.000682	CcSEcCtD
Clofarabine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	9.59e-05	0.000681	CcSEcCtD
Clofarabine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	9.59e-05	0.000681	CcSEcCtD
Clofarabine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	9.57e-05	0.00068	CcSEcCtD
Clofarabine—Pruritus—Stavudine—acquired immunodeficiency syndrome	9.56e-05	0.000679	CcSEcCtD
Clofarabine—Asthenia—Abacavir—acquired immunodeficiency syndrome	9.55e-05	0.000678	CcSEcCtD
Clofarabine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	9.54e-05	0.000678	CcSEcCtD
Clofarabine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	9.52e-05	0.000676	CcSEcCtD
Clofarabine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	9.52e-05	0.000676	CcSEcCtD
Clofarabine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	9.49e-05	0.000674	CcSEcCtD
Clofarabine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	9.49e-05	0.000674	CcSEcCtD
Clofarabine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	9.49e-05	0.000674	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	9.46e-05	0.000671	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	9.43e-05	0.000669	CcSEcCtD
Clofarabine—Pruritus—Abacavir—acquired immunodeficiency syndrome	9.41e-05	0.000668	CcSEcCtD
Clofarabine—Fatigue—Indinavir—acquired immunodeficiency syndrome	9.41e-05	0.000668	CcSEcCtD
Clofarabine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	9.41e-05	0.000668	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	9.4e-05	0.000667	CcSEcCtD
Clofarabine—Cough—Saquinavir—acquired immunodeficiency syndrome	9.39e-05	0.000667	CcSEcCtD
Clofarabine—Pain—Indinavir—acquired immunodeficiency syndrome	9.34e-05	0.000663	CcSEcCtD
Clofarabine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	9.29e-05	0.00066	CcSEcCtD
Clofarabine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	9.28e-05	0.000659	CcSEcCtD
Clofarabine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	9.28e-05	0.000659	CcSEcCtD
Clofarabine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.27e-05	0.000658	CcSEcCtD
Clofarabine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	9.26e-05	0.000658	CcSEcCtD
Clofarabine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.24e-05	0.000656	CcSEcCtD
Clofarabine—Nausea—Didanosine—acquired immunodeficiency syndrome	9.24e-05	0.000656	CcSEcCtD
Clofarabine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	9.22e-05	0.000655	CcSEcCtD
Clofarabine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	9.2e-05	0.000653	CcSEcCtD
Clofarabine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	9.19e-05	0.000653	CcSEcCtD
Clofarabine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	9.17e-05	0.000651	CcSEcCtD
Clofarabine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	9.16e-05	0.000651	CcSEcCtD
Clofarabine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	9.16e-05	0.000651	CcSEcCtD
Clofarabine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	9.13e-05	0.000648	CcSEcCtD
Clofarabine—Oedema—Ritonavir—acquired immunodeficiency syndrome	9.13e-05	0.000648	CcSEcCtD
Clofarabine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	9.1e-05	0.000646	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	9.1e-05	0.000646	CcSEcCtD
Clofarabine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	9e-05	0.000639	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	8.99e-05	0.000639	CcSEcCtD
Clofarabine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	8.97e-05	0.000637	CcSEcCtD
Clofarabine—Cough—Lamivudine—acquired immunodeficiency syndrome	8.96e-05	0.000636	CcSEcCtD
Clofarabine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	8.96e-05	0.000636	CcSEcCtD
Clofarabine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	8.95e-05	0.000636	CcSEcCtD
Clofarabine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	8.94e-05	0.000635	CcSEcCtD
Clofarabine—Dizziness—Stavudine—acquired immunodeficiency syndrome	8.93e-05	0.000634	CcSEcCtD
Clofarabine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	8.93e-05	0.000634	CcSEcCtD
Clofarabine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	8.91e-05	0.000633	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	8.91e-05	0.000632	CcSEcCtD
Clofarabine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	8.9e-05	0.000632	CcSEcCtD
Clofarabine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	8.89e-05	0.000632	CcSEcCtD
Clofarabine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	8.87e-05	0.00063	CcSEcCtD
Clofarabine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	8.86e-05	0.000629	CcSEcCtD
Clofarabine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	8.82e-05	0.000627	CcSEcCtD
Clofarabine—Pain—Efavirenz—acquired immunodeficiency syndrome	8.82e-05	0.000626	CcSEcCtD
Clofarabine—Rash—Nevirapine—acquired immunodeficiency syndrome	8.82e-05	0.000626	CcSEcCtD
Clofarabine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	8.81e-05	0.000626	CcSEcCtD
Clofarabine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	8.8e-05	0.000625	CcSEcCtD
Clofarabine—Dizziness—Abacavir—acquired immunodeficiency syndrome	8.8e-05	0.000625	CcSEcCtD
Clofarabine—Oedema—Saquinavir—acquired immunodeficiency syndrome	8.79e-05	0.000624	CcSEcCtD
Clofarabine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	8.78e-05	0.000623	CcSEcCtD
Clofarabine—Headache—Nevirapine—acquired immunodeficiency syndrome	8.76e-05	0.000622	CcSEcCtD
Clofarabine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	8.74e-05	0.000621	CcSEcCtD
Clofarabine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	8.74e-05	0.000621	CcSEcCtD
Clofarabine—Infection—Saquinavir—acquired immunodeficiency syndrome	8.73e-05	0.00062	CcSEcCtD
Clofarabine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	8.71e-05	0.000619	CcSEcCtD
Clofarabine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	8.7e-05	0.000618	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	8.68e-05	0.000617	CcSEcCtD
Clofarabine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	8.63e-05	0.000613	CcSEcCtD
Clofarabine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	8.63e-05	0.000613	CcSEcCtD
Clofarabine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	8.62e-05	0.000612	CcSEcCtD
Clofarabine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	8.62e-05	0.000612	CcSEcCtD
Clofarabine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	8.6e-05	0.000611	CcSEcCtD
Clofarabine—Vomiting—Stavudine—acquired immunodeficiency syndrome	8.59e-05	0.00061	CcSEcCtD
Clofarabine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	8.58e-05	0.000609	CcSEcCtD
Clofarabine—Rash—Nelfinavir—acquired immunodeficiency syndrome	8.54e-05	0.000607	CcSEcCtD
Clofarabine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	8.54e-05	0.000606	CcSEcCtD
Clofarabine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	8.53e-05	0.000606	CcSEcCtD
Clofarabine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	8.53e-05	0.000606	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	8.52e-05	0.000605	CcSEcCtD
Clofarabine—Rash—Stavudine—acquired immunodeficiency syndrome	8.52e-05	0.000605	CcSEcCtD
Clofarabine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	8.51e-05	0.000604	CcSEcCtD
Clofarabine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	8.51e-05	0.000604	CcSEcCtD
Clofarabine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	8.5e-05	0.000604	CcSEcCtD
Clofarabine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	8.49e-05	0.000603	CcSEcCtD
Clofarabine—Headache—Nelfinavir—acquired immunodeficiency syndrome	8.49e-05	0.000603	CcSEcCtD
Clofarabine—Headache—Stavudine—acquired immunodeficiency syndrome	8.46e-05	0.000601	CcSEcCtD
Clofarabine—Vomiting—Abacavir—acquired immunodeficiency syndrome	8.46e-05	0.000601	CcSEcCtD
Clofarabine—Pain—Delavirdine—acquired immunodeficiency syndrome	8.44e-05	0.000599	CcSEcCtD
Clofarabine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	8.44e-05	0.000599	CcSEcCtD
Clofarabine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.42e-05	0.000598	CcSEcCtD
Clofarabine—Rash—Abacavir—acquired immunodeficiency syndrome	8.39e-05	0.000596	CcSEcCtD
Clofarabine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	8.38e-05	0.000595	CcSEcCtD
Clofarabine—Oedema—Lamivudine—acquired immunodeficiency syndrome	8.38e-05	0.000595	CcSEcCtD
Clofarabine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	8.37e-05	0.000595	CcSEcCtD
Clofarabine—Headache—Abacavir—acquired immunodeficiency syndrome	8.34e-05	0.000592	CcSEcCtD
Clofarabine—Infection—Lamivudine—acquired immunodeficiency syndrome	8.33e-05	0.000591	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.32e-05	0.00059	CcSEcCtD
Clofarabine—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.31e-05	0.00059	CcSEcCtD
Clofarabine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.31e-05	0.00059	CcSEcCtD
Clofarabine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	8.22e-05	0.000584	CcSEcCtD
Clofarabine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	8.21e-05	0.000583	CcSEcCtD
Clofarabine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	8.21e-05	0.000583	CcSEcCtD
Clofarabine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	8.2e-05	0.000582	CcSEcCtD
Clofarabine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.16e-05	0.000579	CcSEcCtD
Clofarabine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	8.16e-05	0.000579	CcSEcCtD
Clofarabine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	8.14e-05	0.000578	CcSEcCtD
Clofarabine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	8.14e-05	0.000578	CcSEcCtD
Clofarabine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.13e-05	0.000578	CcSEcCtD
Clofarabine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	8.11e-05	0.000576	CcSEcCtD
Clofarabine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	8.1e-05	0.000575	CcSEcCtD
Clofarabine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	8.07e-05	0.000573	CcSEcCtD
Clofarabine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.05e-05	0.000571	CcSEcCtD
Clofarabine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	8.04e-05	0.000571	CcSEcCtD
Clofarabine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.03e-05	0.00057	CcSEcCtD
Clofarabine—Nausea—Stavudine—acquired immunodeficiency syndrome	8.02e-05	0.00057	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	8e-05	0.000568	CcSEcCtD
Clofarabine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	7.99e-05	0.000567	CcSEcCtD
Clofarabine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	7.93e-05	0.000563	CcSEcCtD
Clofarabine—Nausea—Abacavir—acquired immunodeficiency syndrome	7.9e-05	0.000561	CcSEcCtD
Clofarabine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	7.89e-05	0.00056	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	7.88e-05	0.00056	CcSEcCtD
Clofarabine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	7.87e-05	0.000559	CcSEcCtD
Clofarabine—Asthenia—Indinavir—acquired immunodeficiency syndrome	7.83e-05	0.000556	CcSEcCtD
Clofarabine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	7.83e-05	0.000556	CcSEcCtD
Clofarabine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	7.83e-05	0.000556	CcSEcCtD
Clofarabine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	7.81e-05	0.000555	CcSEcCtD
Clofarabine—Pain—Ritonavir—acquired immunodeficiency syndrome	7.81e-05	0.000554	CcSEcCtD
Clofarabine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	7.8e-05	0.000554	CcSEcCtD
Clofarabine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	7.8e-05	0.000554	CcSEcCtD
Clofarabine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	7.76e-05	0.000551	CcSEcCtD
Clofarabine—Pruritus—Indinavir—acquired immunodeficiency syndrome	7.73e-05	0.000549	CcSEcCtD
Clofarabine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	7.64e-05	0.000542	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	7.64e-05	0.000542	CcSEcCtD
Clofarabine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	7.6e-05	0.00054	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	7.58e-05	0.000539	CcSEcCtD
Clofarabine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	7.57e-05	0.000538	CcSEcCtD
Clofarabine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	7.53e-05	0.000534	CcSEcCtD
Clofarabine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	7.52e-05	0.000534	CcSEcCtD
Clofarabine—Pain—Saquinavir—acquired immunodeficiency syndrome	7.51e-05	0.000533	CcSEcCtD
Clofarabine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	7.47e-05	0.000531	CcSEcCtD
Clofarabine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.47e-05	0.00053	CcSEcCtD
Clofarabine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	7.47e-05	0.00053	CcSEcCtD
Clofarabine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	7.46e-05	0.00053	CcSEcCtD
Clofarabine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	7.45e-05	0.000529	CcSEcCtD
Clofarabine—Rash—Zidovudine—acquired immunodeficiency syndrome	7.4e-05	0.000526	CcSEcCtD
Clofarabine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.4e-05	0.000526	CcSEcCtD
Clofarabine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.4e-05	0.000525	CcSEcCtD
Clofarabine—Headache—Zidovudine—acquired immunodeficiency syndrome	7.36e-05	0.000522	CcSEcCtD
Clofarabine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.3e-05	0.000518	CcSEcCtD
Clofarabine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	7.29e-05	0.000517	CcSEcCtD
Clofarabine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	7.27e-05	0.000516	CcSEcCtD
Clofarabine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.24e-05	0.000514	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.24e-05	0.000514	CcSEcCtD
Clofarabine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.23e-05	0.000513	CcSEcCtD
Clofarabine—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.22e-05	0.000513	CcSEcCtD
Clofarabine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.22e-05	0.000512	CcSEcCtD
Clofarabine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.22e-05	0.000512	CcSEcCtD
Clofarabine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	7.18e-05	0.00051	CcSEcCtD
Clofarabine—Pain—Lamivudine—acquired immunodeficiency syndrome	7.17e-05	0.000509	CcSEcCtD
Clofarabine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.08e-05	0.000503	CcSEcCtD
Clofarabine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.06e-05	0.000501	CcSEcCtD
Clofarabine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	6.98e-05	0.000496	CcSEcCtD
Clofarabine—Nausea—Zidovudine—acquired immunodeficiency syndrome	6.97e-05	0.000495	CcSEcCtD
Clofarabine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	6.95e-05	0.000493	CcSEcCtD
Clofarabine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	6.95e-05	0.000493	CcSEcCtD
Clofarabine—Vomiting—Indinavir—acquired immunodeficiency syndrome	6.94e-05	0.000493	CcSEcCtD
Clofarabine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	6.91e-05	0.00049	CcSEcCtD
Clofarabine—Rash—Indinavir—acquired immunodeficiency syndrome	6.88e-05	0.000489	CcSEcCtD
Clofarabine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	6.88e-05	0.000488	CcSEcCtD
Clofarabine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	6.85e-05	0.000487	CcSEcCtD
Clofarabine—Headache—Indinavir—acquired immunodeficiency syndrome	6.84e-05	0.000486	CcSEcCtD
Clofarabine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	6.82e-05	0.000484	CcSEcCtD
Clofarabine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	6.75e-05	0.00048	CcSEcCtD
Clofarabine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	6.73e-05	0.000478	CcSEcCtD
Clofarabine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	6.63e-05	0.00047	CcSEcCtD
Clofarabine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	6.63e-05	0.00047	CcSEcCtD
Clofarabine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	6.56e-05	0.000466	CcSEcCtD
Clofarabine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.55e-05	0.000465	CcSEcCtD
Clofarabine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	6.53e-05	0.000463	CcSEcCtD
Clofarabine—Rash—Efavirenz—acquired immunodeficiency syndrome	6.5e-05	0.000462	CcSEcCtD
Clofarabine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	6.5e-05	0.000461	CcSEcCtD
Clofarabine—Nausea—Indinavir—acquired immunodeficiency syndrome	6.49e-05	0.000461	CcSEcCtD
Clofarabine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	6.47e-05	0.00046	CcSEcCtD
Clofarabine—Headache—Efavirenz—acquired immunodeficiency syndrome	6.46e-05	0.000459	CcSEcCtD
Clofarabine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.46e-05	0.000459	CcSEcCtD
Clofarabine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.3e-05	0.000448	CcSEcCtD
Clofarabine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.28e-05	0.000446	CcSEcCtD
Clofarabine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.25e-05	0.000443	CcSEcCtD
Clofarabine—Rash—Delavirdine—acquired immunodeficiency syndrome	6.22e-05	0.000442	CcSEcCtD
Clofarabine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.22e-05	0.000441	CcSEcCtD
Clofarabine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.22e-05	0.000441	CcSEcCtD
Clofarabine—Headache—Delavirdine—acquired immunodeficiency syndrome	6.18e-05	0.000439	CcSEcCtD
Clofarabine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.18e-05	0.000438	CcSEcCtD
Clofarabine—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.13e-05	0.000435	CcSEcCtD
Clofarabine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.04e-05	0.000429	CcSEcCtD
Clofarabine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.01e-05	0.000427	CcSEcCtD
Clofarabine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.01e-05	0.000427	CcSEcCtD
Clofarabine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	5.93e-05	0.000421	CcSEcCtD
Clofarabine—Nausea—Delavirdine—acquired immunodeficiency syndrome	5.86e-05	0.000416	CcSEcCtD
Clofarabine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	5.81e-05	0.000413	CcSEcCtD
Clofarabine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	5.8e-05	0.000412	CcSEcCtD
Clofarabine—Rash—Ritonavir—acquired immunodeficiency syndrome	5.76e-05	0.000409	CcSEcCtD
Clofarabine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	5.75e-05	0.000408	CcSEcCtD
Clofarabine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	5.73e-05	0.000407	CcSEcCtD
Clofarabine—Headache—Ritonavir—acquired immunodeficiency syndrome	5.72e-05	0.000406	CcSEcCtD
Clofarabine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.59e-05	0.000397	CcSEcCtD
Clofarabine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	5.54e-05	0.000394	CcSEcCtD
Clofarabine—Rash—Saquinavir—acquired immunodeficiency syndrome	5.54e-05	0.000393	CcSEcCtD
Clofarabine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.53e-05	0.000393	CcSEcCtD
Clofarabine—Headache—Saquinavir—acquired immunodeficiency syndrome	5.5e-05	0.000391	CcSEcCtD
Clofarabine—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.42e-05	0.000385	CcSEcCtD
Clofarabine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.33e-05	0.000378	CcSEcCtD
Clofarabine—Rash—Lamivudine—acquired immunodeficiency syndrome	5.28e-05	0.000375	CcSEcCtD
Clofarabine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.28e-05	0.000375	CcSEcCtD
Clofarabine—Headache—Lamivudine—acquired immunodeficiency syndrome	5.25e-05	0.000373	CcSEcCtD
Clofarabine—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.22e-05	0.000371	CcSEcCtD
Clofarabine—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.98e-05	0.000353	CcSEcCtD
